Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Progressive | PGR | Apr 24, 2024 | 212.20 | -0.85 |
Progyny | PGNY | Apr 24, 2024 | 32.60 | +0.62 |
Project Energy Reimagined Acquisition A | PEGR | Apr 24, 2024 | 8.45 | -2.76 |
Project Energy Reimagined Acquisition Unit | PEGRU | Apr 24, 2024 | 8.13 | -25.48 |
ProKidney | PROK | Apr 24, 2024 | 2.71 | +7.11 |
Prologis | PLD | Apr 24, 2024 | 103.18 | -1.57 |
ProMIS Neurosciences | PMN | Apr 24, 2024 | 1.95 | -4.86 |
PropertyGuru | PGRU | Apr 24, 2024 | 3.74 | -0.27 |
ProPetro | PUMP | Apr 24, 2024 | 8.66 | +0.23 |
ProPhase Labs | PRPH | Apr 24, 2024 | 5.06 | -1.94 |
ProQR Therapeutics | PRQR | Apr 24, 2024 | 2.01 | -0.50 |
PROS | PRO | Apr 24, 2024 | 34.62 | +1.02 |
Proshares Ultra FTSE Europe | UPV | Apr 24, 2024 | 60.35 | -0.94 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Apr 24, 2024 | 71.95 | +9.85 |
Proshares Ultrashort FTSE Europe | EPV | Apr 24, 2024 | 8.15 | +0.99 |
ProSomnus | OSA | Apr 24, 2024 | 0.47 | 0.00 |
Prospect Capital | PSEC | Apr 24, 2024 | 5.50 | +0.46 |
Prospect Capital A Pref | PSEC-A | Apr 24, 2024 | 17.31 | -1.76 |
Prosperity Bancshares | PB | Apr 24, 2024 | 65.08 | +3.80 |
Protagonist Therapeutics | PTGX | Apr 24, 2024 | 25.70 | -4.28 |
Protalix Bio Therapeutics | PLX | Apr 24, 2024 | 1.21 | +0.83 |
Protara Therapeutics | TARA | Apr 24, 2024 | 2.82 | -6.00 |
Prothena | PRTA | Apr 24, 2024 | 20.56 | 0.00 |
Proto Labs | PRLB | Apr 24, 2024 | 31.95 | -0.47 |
Provident Bancorp | PVBC | Apr 24, 2024 | 8.64 | +6.54 |
Provident Financial | PROV | Apr 24, 2024 | 13.00 | +0.08 |
Provident Financial Services | PFS | Apr 24, 2024 | 15.55 | +0.19 |
Prudential ADR | PUK | Apr 24, 2024 | 18.64 | -0.32 |
Prudential Financial | PRU | Apr 24, 2024 | 112.76 | +0.63 |
PSQ Holdings | PSQH | Apr 24, 2024 | 4.28 | +2.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.